are glp- 1 makers being sued The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 Weight-Loss Drug Lawsuits: What Patients

"This should not be considered the easy way out for long-term success

How would the addition of a GLP-1RA compare to other second-line add-on therapies in improving management of the T2DM

Degener Neurol Neuromuscul Dis 12: 3159

After treatment with liraglutide, the glucose content in the culture medium significantly decreased compared with that in the IR cells

It was easy to use and store

Someone carrying extra weight who still runs half marathons, with normal blood sugar, normal labs, and good energy, has what the commission calls preclinical obesity: a state worth watching, with elevated future risk, but not necessarily one that demands aggressive treatment today